writeLaTeX
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | 2.3m | 4.5m | 6.9m | 9.7m | 15.3m | 14.3m |
% growth | 119 % | 155 % | 97 % | 53 % | 41 % | 57 % | (6 %) |
EBITDA | (<1m) | (1.1m) | (<1m) | 1.9m | 3.8m | 6.2m | - |
% EBITDA margin | (95 %) | (50 %) | (6 %) | 27 % | 39 % | 40 % | - |
Profit | (<1m) | (1.2m) | (<1m) | 1.8m | 3.1m | 5.8m | - |
% profit margin | (100 %) | (50 %) | (7 %) | 26 % | 32 % | 38 % | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
€20.9k | Seed | ||
N/A | N/A | Seed | |
N/A | Support Program | ||
Total Funding | CAD31.3k |
Recent News about writeLaTeX
EditOverleaf is a startup and social enterprise that provides modern collaborative authoring tools designed to make science and research faster, more open, and more transparent. The platform is widely used by over six million students, researchers, and educators across 3,600 institutions globally. Overleaf operates in the academic and scientific research market, offering a cloud-based LaTeX editor that simplifies the process of writing, editing, and publishing scientific documents. The business model is subscription-based, generating revenue through individual and institutional subscriptions, as well as premium features and services. Overleaf's tools are particularly beneficial for collaborative projects, enabling multiple users to work on a document simultaneously in real-time, thus enhancing productivity and efficiency in research and teaching.
Keywords: collaborative authoring, LaTeX editor, scientific research, academic publishing, cloud-based, real-time collaboration, subscription model, educational tools, research productivity, transparency.